Featuring Thermo Fisher Scientific, Agilent Technologies, Merck, Eurofins Scientific, Charles River Labs and Other Key ...
An international research team led by scientists from the Max Planck Institute for Marine Microbiology in Bremen and the ...
Microbes in the gut, lungs and biofilms do not simply exist as perfectly mixed populations; instead, they grow in layered and clustered three-dimensional (3D) arrangements. This spatial organization ...
Seizures can race through the brain in seconds, making them difficult to capture in detail. To overcome this challenge, ...
Tuberculosis meningitis treatment may be approaching a turning point: a Cincinnati Children’s-led study in Nature Communications finds semaglutide — the diabetes drug sold as Ozempic — outperforms ...
VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced its first commercial sales in ...
Patient-derived organoids contribute to precision medicine by enabling direct drug testing on a patient’s tumor. These models ...
Researchers from UTS and Monash University have identified vitronectin as a key protein driving abnormal lung scarring in ...
VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced revenue ...
ARPA-H gene editing program THRIVE awards $160 million to seven research teams tasked with building scalable base-editing ...
Auxilium says it bioprinted kidney and liver tissue on the ISS, a first. The near-term payoff is drug-testing organoids, not transplant organs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results